Ghent University Academic Bibliography

Journal Article
A1
open access

Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

Saartje Uyttebroek, Lieven Dupont, Jeroen Wagemans, Rob Lavigne, Maya Merabishvili, Tom Coenye (UGent) and Laura Van Gerven

(2025) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 15(1). p.73-76

Add to list

Journal Article
A1
open access

Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis

Manon Blauwblomme (UGent) , Christos Georgalas, Shahzada Ahmed, Isam Alobid, Paolo Battaglia, Paolo Castelnuovo, Jannis Constantinidis, Iacopo Dallan, Anne‐Sophie Eeckels, Marco Ferrari, et al.

(2025) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 15(3). p.303-316

Add to list

Journal Article
A1
open access

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps : an analysis of randomized clinical trials

Eli O. Meltzer, Joaquim Mullol, Jinnie Ko, Rebecca Saenz, John W. Steinke, Lauren A. Millette and Philippe Gevaert (UGent)

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(7). p.1163-1172

Add to list

Journal Article
A1
open access

International Consensus Statement on Allergy and Rhinology : Sinonasal Tumors

Edward C. Kuan, Eric W. Wang, Nithin D. Adappa, Daniel M. Beswick, Nyall R. London, Shirley Y. Su, Marilene B. Wang, Waleed M. Abuzeid, Borislav Alexiev, Jeremiah A. Alt, et al.

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(2). p.149-608

Add to list

Journal Article
A1
open access

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter Hellings (UGent) , Joseph K. Han, Anju T. Peters, Jared Silver, Steven G. Smith, Abigail Fuller, Ana R. Sousa, et al.

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(1). p.18-31

Add to list

Journal Article
A1
open access

The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps

Philippe Gevaert (UGent) , Joseph K. Han, Steven G. Smith, Ana R. Sousa, Peter H. Howarth, Steven W. Yancey, Robert Chan and Claus Bachert (UGent)

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 12(11). p.1413-1423

Add to list

Miscellaneous
open access

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Claus Bachert (UGent) , Jonathan Corren, Stella E. Lee, Haixin Zhang, Sivan Harel, Danen Cunoosamy, Asif H. Khan, Juby A. Jacob‐Nara, Shahid Siddiqui, Scott Nash, et al.

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 12(9). p.1191-1195

Add to list

Miscellaneous
open access

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter Hellings (UGent) , Anju T Peters, Adam M Chaker, Enrico Heffler, Haixin Zhang, Amy Praestgaard, Scott Nash, Asif H. Khan, Shahid Siddiqui, Juby A Jacob-Nara, et al.

(2022) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 12(7). p.958-962

Add to list

International consensus statement : spontaneous cerebrospinal fluid rhinorrhea

Christos Georgalas, Amanda Oostra, Shahzada Ahmed, Paolo Castelnuovo, Iacopo Dallan, Wouter Furth, Richard J. Harvey, Philippe Herman, Dimitrios Kombogiorgas, Davide Locatelli, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(4). p.794-803

Add to list

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Claire Hopkins, Martin Wagenmann, Claus Bachert (UGent) , Martin Desrosiers, Joseph K. Han, Peter W. Hellings, Stella E. Lee, Jerome Msihid, Amr Radwan, Paul Rowe, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(7). p.1087-1101

Academic Bibliography

Evaluation of antibiofilm agents for treatment of cystic fibrosis-related chronic rhinosinusitis

Expert consensus on surgical management of primary diffuse type 2‐dominant chronic rhinosinusitis

Omalizumab improves sleep and health status for patients with chronic rhinosinusitis with nasal polyps : an analysis of randomized clinical trials

International Consensus Statement on Allergy and Rhinology : Sinonasal Tumors

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

International consensus statement : spontaneous cerebrospinal fluid rhinorrhea

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Contents

Support

Contact